BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Scaccabarozzi, L. [1 ]
Asano, E. [1 ]
Guimaraes, T. B. [1 ]
机构：
[1] Janssen, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1038
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY20
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [31] RETRACTION: Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta-analysis (Retraction of Vol 29, art no 1813, 2020)
    Abdulla, Jami Sayed
    Shi, Jiandang
    Roy, Brotendu Shekhar
    Zhou Zhanwen
    Liu, Changhao
    EUROPEAN SPINE JOURNAL, 2022, 31 (04) : 1067 - 1067
  • [32] Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
    Nita, Marcelo Eidi
    Eliaschewitz, Freddy G.
    Ribeiro, Eliane
    Asano, Elio
    Barbosa, Elias
    Takemoto, Maira
    Donato, Bonnie
    Rached, Roberto
    Rahal, Elaine
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (03): : 294 - 301
  • [33] Budget impact analysis of abatacept inclusion for moderate to severe rheumatoid arthritis in the Brazilian public system
    Alves, M. R.
    Carvalho, F., Jr.
    Litalien, G.
    VALUE IN HEALTH, 2008, 11 (03) : A256 - A256
  • [34] COST-MINIMIZATION ANALYSIS OF ANTI-TNF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS) PERSPECTIVE
    Scaccabarozzi, L.
    VALUE IN HEALTH, 2014, 17 (03) : A229 - A229
  • [35] BUDGET IMPACT RELATED TO COMPLICATIONS ON POST-BARIATRIC SURGERY PATIENTS IN BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    De Santana, Salgado C.
    Pititto, L.
    Gulart, A.
    Palmanhani, M. R.
    VALUE IN HEALTH, 2022, 25 (12) : S79 - S79
  • [36] BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Barbosa, E.
    Ribeiro, E.
    Asano, E.
    Nita, M.
    Rached, R.
    Mantilla, P.
    Pimentel, A.
    Donato, B. M.
    Rahal, E.
    VALUE IN HEALTH, 2010, 13 (03) : A56 - A57
  • [37] BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF A COMPUTERIZED TEMPERATURE MANAGEMENT SYSTEM IN THE TREATMENT OF THERAPEUTIC HYPOTHERMIA IN GREECE
    Maistreli, S.
    Kourlaba, G.
    Georgopoulos, D.
    Maniadakis, N.
    VALUE IN HEALTH, 2016, 19 (07) : A630 - A631
  • [38] LAPATINIB WITH LETROZOLE AS A TREATMENT STRATEGY FOR PATIENTS WITH METASTATIC BREAST CANCER (HER2) UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM: A BUDGET IMPACT ANALYSIS
    Guimaraes, J. M.
    Fonseca, M. C.
    Costa, D. N.
    Aragao, E. S.
    Abreu, G. R.
    Nita, M. E.
    VALUE IN HEALTH, 2017, 20 (05) : A98 - A98
  • [39] SOMATROPIN DOSE ANALYSIS FOR TREATMENT OF HYPOPITUITARISM IN PUBLIC BRAZILIAN HEALTH SYSTEM (SUS)
    Ferreira, C. N.
    Rufino, C. S.
    Manfrin, D. F.
    VALUE IN HEALTH, 2014, 17 (03) : A243 - A243
  • [40] BUDGETARY IMPACT ANALYSIS OF LEVETIRACETAM USE FOR FOCAL EPILEPSY PATIENTS' TREATMENT WITH OR WITHOUT SECONDARY GENERALIZATION FROM THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE
    Carmo, E.
    Nita, M. E.
    Motta, R.
    Lima, F.
    VALUE IN HEALTH, 2016, 19 (03) : A61 - A61
12345